乌鸦传媒

<乌鸦传媒 class="page-title">Meeting Coverage

ISDS

<乌鸦传媒 class="page-description">Inflammatory Skin Disease Summit
Signs of Relief From 'Therapeutic Drought' in Atopic Dermatitis

Encouraging results from pipeline agents targeting T乌鸦传媒-specific inflammation

ISDS over a photo of the New York Academy of Medicine in New York, NY.
<乌鸦传媒 class="section_title">Latest ISDS Meeting Coverage
Dramatic Responses in Cutaneous Sarcoidosis With JAK Inhibitor

More than 80% reduction in disease activity in case series of tofacitinib treatment

November 7, 2021
Substantial Improvement in Vitiligo With Topical JAK Inhibitor

About 30% of patients had 75% clearance after 6 months, half had 50% clearance

November 6, 2021
Early Success With New Target in Atopic Dermatitis

Inhibition of T乌鸦传媒-related inflammation leads to rapid improvement in disease activity

November 5, 2021
Topical PDE4 Inhibitor Impresses in Trial of Seborrheic Dermatitis

Rapid, persistent improvement in body surface area, itch, other symptoms with roflumilast

November 4, 2021
Two-Drug Regimen Fails to Stem Psoriasis Relapse

Study looks at costimulatory blockade with abatacept after stopping ustekinumab

December 18, 2018
Salt Accumulation May Be a Factor in Atopic Dermatitis

But hypothesis regarding sodium chloride levels in skin needs more work, expert says

December 16, 2018
Skin-Stripping Test Promising for Inflammatory Skin Diseases

Protein analysis may help differentiate between eczema, psoriasis

December 16, 2018
Conjunctivitis Seen in Patients on Dupixent

Effectiveness of agent against atopic dermatitis also makes eyes vulnerable

December 13, 2018
<乌鸦传媒 class="section_title"> Latest Dermatology Meeting Coverage